Creation Date 30-Aug-2011 Revision Date 22-Nov-2011 ... · PDF fileCreation Date 30-Aug-2011 Revision Date 22-Nov-2011 Revision Number 2 Kit Safety Data Sheet Product Name: ... ProClin

Creation Date 30-Aug-2011 Revision Date 22-Nov-2011 Revision Number 2

Kit Safety Data Sheet Product Name: PathoDxtra Strep Grouping Kit

Product Code: DR0700M

Component Safety Data Sheets for Kit

DR0701G-0706G PathoDxtra Strep A, B, C, D, F, G Group Latex Yes DR0707G PathoDxtra Positive Control Yes DR0709A PathoDxtra Extraction Reagent 1 Yes DR0709B PathoDxtra Extraction Reagent 2 Yes DR0709C PathoDxtra Extraction Reagent 3 Yes

Code Component Name SDS Required*

Kit Transport Information UN-No. Not Regulated Hazard Class - Packing Group - Proper Shipping Name -

Emergency contact information: Company Identification: Oxoid Ltd. Wade Road, Basingstoke, Hants, RG24 8PW United Kingdom Company Phone Number: +44 (0) 1256 841144 Emergency Telephone Number Carechem 24: +44 (0) 1865 407333 Email: [email protected] * Kit components labelled as not required above are not included in this SDS and are considered non-hazardous.

1/36

1/36

mailto:[email protected]

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Product Name PathoDxtra Strep A, B, C, D, F, G Group LatexCat No. DR0701 - DR0706Synonyms No information available.Recommended Use Laboratory chemicals

Emergency Telephone Number Carechem 24: +44 (0) 1865 407333

2. HAZARDS IDENTIFICATION

The preparation is classified as dangerous in accordance with Directive 1999/45/EC.

R -phrase(s)R43 - May cause sensitization by skin contact

3. COMPOSITION/INFORMATION ON INGREDIENTS Haz/Non-haz

Component Weight % EC No. Classification Sodium azide 26628-22-8

0.098 EEC No. 247-852-1 T+; R28 R32

N; R50-53ProClin 300 55965-84-9

0.05 - T; R23/24/25 C; R34

R43 N; R50-53

_____________________________________________________________________________________________ Thermo Fisher Scientific

Creation Date 30-Aug-2011

Entity / Business Name Oxoid Ltd.Wade RoadBasingstoke, Hants, UKRG24 8PWTelephone: +44 (0) 1256 841144

E-mail address [email protected]

Revision Date 31-Aug-2011 Revision Number 1

SAFETY DATA SHEET

Page 1 / 7 According to EC Directive 1907/2006/EC

Company REMEL (EUROPE) LIMITEDRemel HouseClipper Boulevard WestCrossways, DartfordKent. DA2 6PTUKTel: (+44) 1322 295600Fax: (+44) 1322 [email protected]

2/36

2/36

_____________________________________________________________________________________________ For the full text of the R phrases mentioned in this Section, see Section 16

4. FIRST AID MEASURES

Eye Contact Rinse thoroughly with plenty of water, also under the eyelids. Get medical attention if

symptoms occur.. Skin Contact Wash off immediately with soap and plenty of water. Get medical attention if symptoms occur.. Ingestion Clean mouth with water and afterwards drink plenty of water. Get medical attention. Inhalation Move to fresh air. Get medical attention if symptoms occur.. Notes to Physician Treat symptomatically.

5. FIRE-FIGHTING MEASURES

Suitable Extinguishing MediaUse extinguishing measures that are appropriate to local circumstances and the surrounding environment Extinguishing media which must not be used for safety reasonsNo information available. Specific Hazards Arising from the ChemicalKeep product and empty container away from heat and sources of ignition Protective Equipment and Precautions for FirefightersAs in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear Flash Point Not applicableMethod No information available. Autoignition Temperature No information available.

6. ACCIDENTAL RELEASE MEASURES

Personal Precautions Avoid contact with skin, eyes and clothing. Ensure adequate ventilation. Environmental Precautions Prevent further leakage or spillage if safe to do so Methods for Containment and Clean Up

Soak up with inert absorbent material. Clean contaminated surface thoroughly


SAFETY DATA SHEET

PathoDxtra Strep A, B, C, D, F, G Group Latex


Revision Date 31-Aug-2011

3/36

3/36

_____________________________________________________________________________________________

7. HANDLING AND STORAGE

Handling Avoid contact with skin, eyes and clothing. Ensure adequate ventilation. Storage Keep container tightly closed. Keep at temperatures between 2° and 8 °C. Specific use(s) No information available.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION Exposure limits

Component European Union The United Kingdom

Belgium France Spain Germany

Sodium azide SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

VME: 0.1 mg/m3 VLCT: 0.3 mg/m3

Skin

Skin VLA-EC: 0.3 mg/m3 VLA-ED: 0.1 mg/m3

MAK 0.2 mg/m3 (inhalable)

Component Italy Portugal The Netherlands Finland AustriaSodium azide TWA: 0.1 mg/m3

STEL: 0.3 mg/m3 Skin

Ceiling: 0.29 mg/m3 Ceiling: 0.11 ppm

Skin STEL: 0.3 mg/m3 TWA: 0.1 mg/m3

TWA: 0.1 mg/m3 STEL: 0.3 mg/m3

Skin

Skin STEL: 0.3 mg/m3 MAK: 0.1 mg/m3

Component Switzerland Poland Norway Ireland Denmark Australia Sodium azide STEL: 0.4 mg/m3

MAK: 0.2 mg/m3NDSCh: 0.3 mg/m3

NDS: 0.1 mg/m3Skin

Ceiling: 0.3 mg/m3TWA: 0.1 mg/m3 STEL: 0.3 mg/m3

Skin

TWA: 0.1 mg/m3 Skin

CL 0.11 ppm (0.3 mg/m3)

Occupational exposure controls Engineering Measures Ensure adequate ventilation, especially in confined areas Personal Protective Equipment Respiratory Protection Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN

149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced

Eye Protection Tightly fitting safety goggles Skin and body protection Wear appropriate protective gloves and clothing to prevent skin exposure Hand Protection Protective gloves

Hygiene Measures Handle in accordance with good industrial hygiene and safety practice Environmental exposure controls No information available.

9. PHYSICAL AND CHEMICAL PROPERTIES


SAFETY DATA SHEET


Page 3 / 7


According to EC Directive 1907/2006/EC

4/36

4/36

_____________________________________________________________________________________________

9. PHYSICAL AND CHEMICAL PROPERTIESPhysical State LiquidAppearance BluepH 7.0 Boiling Point/Range Not applicableMelting Point/Range No information available.Flash Point Not applicable

10. STABILITY AND REACTIVITY

Stability Stable under recommended storage conditions. Conditions to Avoid Incompatible products Incompatible Materials Strong oxidizing agents Hazardous Decomposition Products None under normal use Hazardous Polymerization No information available Hazardous Reactions . None under normal processing.

11. TOXICOLOGICAL INFORMATION

Acute Toxicity

Component Information

Component LD50 Oral LD50 Dermal LC50 InhalationSodium azide 27 mg/kg ( Rat ) 20 mg/kg ( Rabbit )

50 mg/kg ( Rat )ProClin 300 53 mg/kg ( Rat )

Chronic Toxicity Carcinogenicity There are no known carcinogenic chemicals in this product

Sensitization May cause sensitization by skin contact. Neurological Effects No information available. Mutagenic Effects No information available.



Page 4 / 7

SAFETY DATA SHEET



5/36

5/36

_____________________________________________________________________________________________ Reproductive Effects No information available. Developmental Effects No information available. Target Organs No information available.

12. ECOLOGICAL INFORMATION

Ecotoxicity.

Component Freshwater Algae Freshwater Fish Microtox Water FleaSodium azide 0.8 mg/L LC50 96 h

0.7 mg/L LC50 96 h 5.46 mg/L LC50 96 h

ProClin 300 EC50 = 5.7 mg/L 16 h Persistence and Degradability No information available Bioaccumulative Potential No information available. Mobility No information available.

13. DISPOSAL CONSIDERATIONS

Waste from Residues / Unused Products

Dispose of as hazardous waste in compliance with local and national regulations

Contaminated Packaging Empty containers should be taken for local recycling, recovery or waste disposal

14. TRANSPORT INFORMATION

IMDG/IMO Not regulated

ADR Not regulated

IATA Not regulated


PathoDxtra Strep A, B, C, D, F, G Group Latex Revision Date 31-Aug-2011


SAFETY DATA SHEET 6/36

6/36

_____________________________________________________________________________________________

15. REGULATORY INFORMATION

The preparation is classified as dangerous in accordance with Directive 1999/45/EC Labelling

R -phrase(s)R43 - May cause sensitization by skin contact

S -phrase(s) S24/25 - Avoid contact with skin and eyes

International Inventories

Component EINECS ELINCS NLP TSCA DSL NDSL PICCS ENCS CHINA AICS KECL Sodium azide 247-852-1 - X X - X X X X XProClin 300 - - - X - X - X - X

16. OTHER INFORMATION

Text of R phrases mentioned in Section 2-3R28 - Very toxic if swallowedR32 - Contact with acids liberates very toxic gasR34 - Causes burnsR43 - May cause sensitization by skin contactR23/24/25 - Toxic by inhalation, in contact with skin and if swallowedR50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment

Prepared By Regulatory Affairs Creation Date 30-Aug-2011 Revision Date 31-Aug-2011 Revision Summary "***", and red text indicates revision Restrictions on use No information available.


SAFETY DATA SHEET

PathoDxtra Strep A, B, C, D, F, G Group Latex Revision Date 31-Aug-2011


7/36

7/36

_____________________________________________________________________________________________ Training advice No information available. Literary reference No information available. Disclaimer The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.

End of Safety Data Sheet


SAFETY DATA SHEET

Page 7 / 7




8/36

8/36


Product Name PathoDxtra Positive ControlCat No. DR0707Synonyms No information available.Recommended Use Laboratory chemicals



The preparation is non-dangerous in accordance with Directive 1999/45/EC.

R -phrase(s)none


Component Weight % EC No. Classification Sodium azide 26628-22-8

0.098 EEC No. 247-852-1 T+; R28 R32

N; R50-53 For the full text of the R phrases mentioned in this Section, see Section 16









9/36

_____________________________________________________________________________________________



symptoms occur.. Skin Contact Wash off immediately with soap and plenty of water. Get medical attention if symptoms occur.. Ingestion Clean mouth with water and afterwards drink plenty of water. Get medical attention. Inhalation Move to fresh air Notes to Physician Treat symptomatically.




Personal Precautions Avoid contact with the skin and the eyes. Use personal protective equipment. Ensure adequate

ventilation. Environmental Precautions Prevent further leakage or spillage if safe to do so Methods for Containment and Clean Up

Soak up with inert absorbent material Clean contaminated surface thoroughly



Page 2 / 7

SAFETY DATA SHEET


PathoDxtra Positive Control

10/36

10/36

_____________________________________________________________________________________________


Handling Avoid contact with skin, eyes and clothing. Wear personal protective equipment. Storage Keep container tightly closed in a dry and well-ventilated place Specific use(s) No information available.





STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3


Skin








Skin




NDS: 0.1 mg/m3Skin


Skin

TWA: 0.1 mg/m3 Skin

CL 0.11 ppm (0.3 mg/m3)







SAFETY DATA SHEET


Page 3 / 7



11/36

11/36

_____________________________________________________________________________________________

9. PHYSICAL AND CHEMICAL PROPERTIESPhysical State LiquidAppearance ColourlesspH 7.3 - 7.5 Boiling Point/Range Not applicableMelting Point/Range No information available.Flash Point Not applicable


Stability Stable under recommended storage conditions. Conditions to Avoid Incompatible products Incompatible Materials Strong oxidizing agents Hazardous Decomposition Products Nitrogen oxides (NOx), Carbon oxides Hazardous Polymerization No information available Hazardous Reactions . None under normal processing.


Acute Toxicity Product Information Product does not present an acute toxicity hazard based on known or supplied information


Component LD50 Oral LD50 Dermal LC50 InhalationSodium azide 27 mg/kg ( Rat ) 20 mg/kg ( Rabbit )

50 mg/kg ( Rat ) Chronic Toxicity Carcinogenicity There are no known carcinogenic chemicals in this product

Sensitization No information available. Neurological Effects No information available. Mutagenic Effects No information available.


PathoDxtra Positive Control Revision Date 30-Aug-2011



12/36



EcotoxicityNot established. However, at the concentration present, this preparation is not expected to present significant adverse environmental effects.


0.7 mg/L LC50 96 h 5.46 mg/L LC50 96 h

Persistence and Degradability No information available Bioaccumulative Potential No information available. Mobility No information available.



Dispose of in accordance with local regulations




ADR Not regulated

IATA Not regulated


SAFETY DATA SHEET




13/36

13/36

_____________________________________________________________________________________________


The preparation is non-dangerous in accordance with Directive 1999/45/EC Labelling

R -phrase(s)none



Component EINECS ELINCS NLP TSCA DSL NDSL PICCS ENCS CHINA AICS KECL Sodium azide 247-852-1 - X X - X X X X X


Text of R phrases mentioned in Section 2-3R28 - Very toxic if swallowedR32 - Contact with acids liberates very toxic gasR50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment

Prepared By Regulatory Affairs Creation Date 30-Aug-2011 Revision Date 30-Aug-2011 Revision Summary "***", and red text indicates revision Restrictions on use No information available. Training advice No information available. Literary reference No information available. Disclaimer The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.


SAFETY DATA SHEET




14/36

14/36

_____________________________________________________________________________________________



SAFETY DATA SHEET




15/36

15/36

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Product Name PathoDxtra Extraction Reagent 1Cat No. DR0709ASynonyms No information available.Recommended Use Laboratory chemicals



The preparation is classified as dangerous in accordance with Directive 1999/45/EC.

R-phrase(s)R25 - Toxic if swallowed


Component Weight % EC-No. Classification Sodium nitrite

7632-00-06.9 EEC No. 231-555-9 T; R25

N; R50 O; R8

Sodium azide 26628-22-8

0.098 EEC No. 247-852-1 T+; R28 R32

N; R50-53





Revision Date 22-Nov-2011 Revision Number 2

SAFETY DATA SHEET



16/36

16/36

_____________________________________________________________________________________________ For the full text of the R phrases mentioned in this Section, see Section 16


Eye Contact Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Get

medical attention if irritation persists.. Skin Contact Wash off immediately with soap and plenty of water. Get medical attention if irritation develops

and persists.. Ingestion Clean mouth with water and drink afterwards plenty of water. Call a physician or Poison Control

Centre immediately. Inhalation Move to fresh air. If symptoms persist, obtain medical attention.. Notes to Physician Treat symptomatically.


Suitable Extinguishing MediaUse extinguishing measures that are appropriate to local circumstances and the surrounding environment Extinguishing media which must not be used for safety reasonsNo information available. Specific Hazards Arising from the ChemicalKeep product and empty container away from heat and sources of ignition Protective Equipment and Precautions for FirefightersAs in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear Flash Point No information available.Method No information available. Autoignition Temperature No information available.


Personal Precautions Ensure adequate ventilation. Use personal protective equipment. Environmental Precautions Prevent further leakage or spillage if safe to do so Methods for Containment and Clean Up

Soak up with inert absorbent material After cleaning, flush away traces with water


SAFETY DATA SHEET

PathoDxtra Extraction Reagent 1


Revision Date 22-Nov-2011

17/36

17/36

_____________________________________________________________________________________________


Handling Avoid contact with skin, eyes and clothing. Ensure adequate ventilation. Storage Keep at temperatures between 2° and 8 °C. Specific use(s) No information available.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION Exposure limits




STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

VME: 0.1 mg/m3 8 heures. restrictive

limit VLCT: 0.3 mg/m3

Skin

Skin VLA-EC: 0.3 mg/m3

15 minutos VLA-ED: 0.1 mg/m3

8 horas


Component Italy Portugal The Netherlands Finland AustriaSodium azide TWA: 0.1 mg/m3 8 ore.

STEL: 0.3 mg/m3 15 minuti. Skin


Skin STEL: 0.3 mg/m3 15

minuten TWA: 0.1 mg/m3 8 uren

TWA: 0.1 mg/m3 8 tunteina

STEL: 0.3 mg/m3 15 minuutteina

Skin

Skin STEL: 0.3 mg/m3 15

Minuten MAK: 0.1 mg/m3 8

Stunden

Component Switzerland Poland Norway Ireland Denmark Australia Sodium azide STEL: 0.4 mg/m3 15

Minuten MAK: 0.2 mg/m3 8

Stunden

NDSCh: 0.3 mg/m3 15 minutach

NDS: 0.1 mg/m3 8 godzinach

Skin Ceiling: 0.3 mg/m3

TWA: 0.1 mg/m3 8 hr. NaN3

STEL: 0.3 mg/m3 15 min Skin

TWA: 0.1 mg/m3 8 timer Skin

CL 0.11 ppm (0.3 mg/m3)


PathoDxtra Extraction Reagent 1 Revision Date 22-Nov-2011



18/36

_____________________________________________________________________________________________ Occupational exposure controls Engineering Measures Ensure adequate ventilation, especially in confined areas Personal Protective Equipment Respiratory Protection Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN





Physical State LiquidAppearance BluepH 9.2 Boiling Point/Range Not applicableMelting Point/Range No information available.Flash Point No information available.


Stability Stable under recommended storage conditions. Conditions to Avoid Temperatures above 537°C. Incompatible Materials Combustible material, Strong oxidizing agents Hazardous Decomposition Products Carbon oxides, Nitrogen oxides (NOx) Hazardous Polymerization Hazardous polymerization does not occur. Hazardous Reactions . None under normal processing.


Acute Toxicity Product Information Product is toxic by ingestion



Page 4 / 7

SAFETY DATA SHEET



19/36

19/36

_____________________________________________________________________________________________


Component LD50 Oral LD50 Dermal LC50 InhalationSodium nitrite 85 mg/kg ( Rat ) 5.5 mg/L ( Rat ) 4 hSodium azide 27 mg/kg ( Rat ) 20 mg/kg ( Rabbit )

50 mg/kg ( Rat ) Chronic Toxicity Carcinogenicity The table below indicates whether each agency has listed any ingredient as a carcinogen

Component IARC UK Sodium nitrite Group 2A

IARC: (International Agency for Research on Cancer)IARC: (International Agency for Research on Cancer)Group 1 - Carcinogenic to HumansGroup 2A - Probably Carcinogenic to HumansGroup 2B - Possibly Carcinogenic to Humans

Sensitization No information available. Neurological Effects No information available. Mutagenic Effects No information available. Reproductive Effects No information available. Developmental Effects No information available. Target Organs No information available.


EcotoxicityVery toxic to aquatic organisms. However, at the concentration present, this preparation is not expected to present significant adverse environmental effects.

Component Freshwater Algae Freshwater Fish Microtox Water FleaSodium nitrite Oncorhynchus mykiss: LC50

= 0.09-0.13 mg/L 96h12.5-100 mg/L 48h

Sodium azide 0.8 mg/L LC50 96 h 0.7 mg/L LC50 96 h

5.46 mg/L LC50 96 h Persistence and Degradability No information available


SAFETY DATA SHEET


Page 5 / 7



20/36

20/36

_____________________________________________________________________________________________ Bioaccumulative Potential No information available. Mobility No information available.

Component log PowSodium nitrite -3.7



Dispose of as hazardous waste in compliance with local and national regulations

Contaminated Packaging Dispose of in accordance with federal, state, and local regulations..



ADR Not regulated

IATA Not regulated


The preparation is classified as dangerous in accordance with Directive 1999/45/EC Labelling

R-phrase(s)R25 - Toxic if swallowed


SAFETY DATA SHEET



21/36

21/36

_____________________________________________________________________________________________ S-phrase(s)S37 - Wear suitable glovesS45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible)


Component EINECS ELINCS NLP TSCA DSL NDSL PICCS ENCS CHINA AICS KECL Sodium nitrite 231-555-9 - X X - X X X X XSodium azide 247-852-1 - X X - X X X X X


Full text of R-phrases referred to under sections 2 and 3R 8 - Contact with combustible material may cause fireR25 - Toxic if swallowedR28 - Very toxic if swallowedR32 - Contact with acids liberates very toxic gasR50 - Very toxic to aquatic organismsR50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment

Prepared By Regulatory Affairs Creation Date 30-Aug-2011 Revision Date 22-Nov-2011 Revision Summary (M)SDS sections updated: 14. Restrictions on use No information available. Training advice No information available. Literary reference No information available. Disclaimer The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.






22/36


Product Name PathoDxtra Extraction Reagent 2Cat No. DR0709BSynonyms No information available.Recommended Use Laboratory chemicals




R -phrase(s)none


Component Weight % EC No. Classification Acetic acid

64-19-78.6 EEC No. 200-580-7 R10

C; R35

For the full text of the R phrases mentioned in this Section, see Section 16









23/36

_____________________________________________________________________________________________


Eye Contact Rinse thoroughly with plenty of water, also under the eyelids. Obtain medical attention. Skin Contact Wash off immediately with plenty of water.. Obtain medical attention if irritation persists. Ingestion Clean mouth with water and afterwards drink plenty of water. Obtain medical attention. Inhalation Move to fresh air. Get medical attention if symptoms occur.. Notes to Physician Treat symptomatically.








Page 2 / 7

SAFETY DATA SHEET



24/36

24/36

_____________________________________________________________________________________________






Acetic acid - STEL: 37 mg/m3 STEL: 15 ppm TWA: 10 ppm

TWA: 25 mg/m3

STEL: 15 ppm STEL: 38 mg/m3

TWA: 10 ppm TWA: 25 mg/m3

VLCT: 10 ppm VLCT: 25 mg/m3

VLA-EC: 15 ppm VLA-EC: 37 mg/m3 VLA-ED: 10 ppm

VLA-ED: 25 mg/m3

MAK: 10 ppm MAK: 25 mg/m3 Peak: 20 ppm

Peak: 50 mg/m3

Component Italy Portugal The Netherlands Finland AustriaAcetic acid - STEL: 15 ppm

TWA: 10 ppmMAC-TGG 25 mg/m3 TWA: 5 ppm

TWA: 13 mg/m3 STEL: 10 ppm

STEL: 25 mg/m3


MAK: 10 ppm MAK: 25 mg/m3

Component Switzerland Poland Norway Ireland Denmark Australia Acetic acid STEL: 20 ppm

STEL: 50 mg/m3 MAK: 10 ppm

MAK: 25 mg/m3

NDSCh: 30 mg/m3 NDS: 15 mg/m3


TWA: 10 ppm TWA: 25 mg/m3 STEL: 15 ppm

STEL: 37 mg/m3










Page 3 / 7

SAFETY DATA SHEET



25/36

25/36

_____________________________________________________________________________________________


Physical State LiquidAppearance Purple pH 2.4 Boiling Point/Range Not applicableMelting Point/Range No information available.Flash Point Not applicable


Stability Stable under recommended storage conditions. Conditions to Avoid Keep away from open flames, hot surfaces and sources of ignition. Incompatible Materials Strong oxidizing agents Hazardous Decomposition Products None under normal use Hazardous Polymerization No information available Hazardous Reactions . None under normal processing.




Component LD50 Oral LD50 Dermal LC50 InhalationAcetic acid 3310 mg/kg ( Rat ) 1060 mg/kg ( Rabbit ) 11.4 mg/L ( Rat ) 4 h





SAFETY DATA SHEET



26/36

26/36

_____________________________________________________________________________________________ Reproductive Effects No information available. Developmental Effects No information available. Target Organs Respiratory system, Eyes, Teeth, Skin.


Ecotoxicity.

Component Freshwater Algae Freshwater Fish Microtox Water FleaAcetic acid Pimephales promelas: LC50

= 88 mg/L/96hLepomis macrochirus: LC50 =

75 mg/L/96h

Photobacterium phosphoreum: EC50 = 8.8

mg/L/15 min Photobacterium

phosphoreum: EC50 = 8.8 mg/L/25 min

Photobacterium phosphoreum: EC50 = 8.8

mg/L/5 min

EC50 = 95 mg/L/24h


Component log PowAcetic acid -0.2







ADR Not regulated


SAFETY DATA SHEET




27/36

27/36

_____________________________________________________________________________________________

14. TRANSPORT INFORMATIONIATA Not regulated



R -phrase(s)none



Component EINECS ELINCS NLP TSCA DSL NDSL PICCS ENCS CHINA AICS KECL Acetic acid 200-580-7 - X X - X X X X X


Text of R phrases mentioned in Section 2-3R10 - FlammableR35 - Causes severe burns

Prepared By Regulatory Affairs Creation Date 30-Aug-2011 Revision Date 30-Aug-2011 Revision Summary "***", and red text indicates revision Restrictions on use No information available. Training advice No information available. Literary reference No information available.


PathoDxtra Extraction Reagent 2 Revision Date 30-Aug-2011



28/36

_____________________________________________________________________________________________ Disclaimer The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.



SAFETY DATA SHEET


Page 7 / 7



29/36

29/36


Product Name PathoDxtra Extraction Reagent 3Cat No. DR0709CSynonyms No information available.Recommended Use Laboratory chemicals




R -phrase(s)none


Component Weight % EC No. Classification Tris (hydroxymethyl)

aminomethane 77-86-1

3.63 EEC No. 201-064-4 Xi; R36/37/38

Sodium azide 26628-22-8

0.098 EEC No. 247-852-1 T+; R28 R32

N; R50-53 For the full text of the R phrases mentioned in this Section, see Section 16





SAFETY DATA SHEET

Page 1 / 7

Company


REMEL (EUROPE) LIMITEDRemel HouseClipper Boulevard WestCrossways, DartfordKent. DA2 6PTUKTel: (+44) 1322 295600Fax: (+44) 1322 [email protected]


30/36

30/36

_____________________________________________________________________________________________



symptoms occur.. Skin Contact Wash off immediately with soap and plenty of water. Get medical attention if symptoms occur.. Ingestion Clean mouth with water and afterwards drink plenty of water. Get medical attention. Inhalation Move to fresh air. Get medical attention if symptoms occur.. Notes to Physician Treat symptomatically.








Page 2 / 7

SAFETY DATA SHEET



31/36

31/36

_____________________________________________________________________________________________







STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3

SkinTWA 0.1 mg/m3

STEL 0.3 mg/m3


Skin








Skin




NDS: 0.1 mg/m3Skin


Skin

TWA: 0.1 mg/m3 Skin

CL 0.11 ppm (0.3 mg/m3)







SAFETY DATA SHEET


Page 3 / 7



32/36

32/36

_____________________________________________________________________________________________

9. PHYSICAL AND CHEMICAL PROPERTIESPhysical State LiquidAppearance ClearpH 10.6 Boiling Point/Range Not applicableMelting Point/Range No information available.Flash Point Not applicable


Stability Stable under recommended storage conditions. Conditions to Avoid Incompatible products Incompatible Materials Strong oxidizing agents Hazardous Decomposition Products None under normal use Hazardous Polymerization No information available Hazardous Reactions . None under normal processing.




Component LD50 Oral LD50 Dermal LC50 InhalationTris (hydroxymethyl) aminomethane 5900 mg/kg ( Rat )

Sodium azide 27 mg/kg ( Rat ) 20 mg/kg ( Rabbit ) 50 mg/kg ( Rat )




SAFETY DATA SHEET

Page 4 / 7




33/36

33/36



Ecotoxicity.


0.7 mg/L LC50 96 h 5.46 mg/L LC50 96 h








ADR Not regulated

IATA Not regulated


SAFETY DATA SHEET




34/36

34/36

_____________________________________________________________________________________________



R -phrase(s)none



Component EINECS ELINCS NLP TSCA DSL NDSL PICCS ENCS CHINA AICS KECL Tris (hydroxymethyl) aminomethane

201-064-4 - X X - X X X X X

Sodium azide 247-852-1 - X X - X X X X X


Text of R phrases mentioned in Section 2-3R28 - Very toxic if swallowedR32 - Contact with acids liberates very toxic gasR36/37/38 - Irritating to eyes, respiratory system and skinR50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment

Prepared By Regulatory Affairs Creation Date 30-Aug-2011 Revision Date 30-Aug-2011 Revision Summary "***", and red text indicates revision Restrictions on use No information available. Training advice No information available. Literary reference No information available.



SAFETY DATA SHEET



35/36

35/36

_____________________________________________________________________________________________ Disclaimer The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.



SAFETY DATA SHEET


Page 7 / 7



36/36

36/36

Documents

Creation Date 30-Aug-2011 Revision Date 22-Nov-2011 ... · PDF fileCreation Date 30-Aug-2011 Revision Date 22-Nov-2011 Revision Number 2 Kit Safety Data Sheet Product Name: ... ProClin